Dr Stephen Krieger describes the topographical model of MS
Topographical Model of MS: a reconceptualization of Multiple Sclerosis clinical course
Dr. Krieger reports consulting or advisory work with Biogen, EMD Serono, Genentech, Genzyme, Mallinckrodt, MedDay, Novartis, Teva, and TG Therapeutics, and non-promotional speaking with Biogen, EMD Serono, Genentech, and Novartis. Grant and research support from Biogen and Novartis.